# A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

> **NCT05775094** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 10 (estimated)

## Conditions studied

- Osteoporosis
- Multiple Myeloma

## Interventions

- **DRUG:** Romosozumab

## Key facts

- **NCT ID:** NCT05775094
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-07
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05775094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05775094, "A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05775094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*